• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

OTU

Supplementary Materials [Supplementary Data] djn178_index. and antitumor efficacy was monitored by

May 15, 2019 by Katherine Lewis Leave a Comment

Supplementary Materials [Supplementary Data] djn178_index. and antitumor efficacy was monitored by quantifying metastasis and survival. Induction of autoimmunity was monitored by histopathology. Mouse monoclonal antibody to HAUSP / USP7. Ubiquitinating enzymes (UBEs) catalyze protein ubiquitination, a reversible process counteredby deubiquitinating enzyme (DUB) action. Five DUB subfamilies are recognized, including theUSP, UCH, OTU, MJD and JAMM … [Read more…]

Posted in: Blogging Tagged: a reversible process counteredby deubiquitinating enzyme DUB) action. Five DUB subfamilies are recognized, HAUSP also modifies other ubiquitinylated proteins such as members of theFoxO family of forkhead transcription factors and the mitotic stress checkpoint protein CHFR, including theUSP, MJD and JAMM enzymes. Herpesvirus-associated ubiquitin-specific proteaseHAUSP, Mouse monoclonal antibody to HAUSP / USP7. Ubiquitinating enzymes UBEs) catalyze protein ubiquitination, OTU, Pexidartinib manufacturer, thereby stabilizing both proteins. In addition to regulating essential components ofthe p53 pathway, UCH, USP7) is an important deubiquitinase belonging to USP subfamily. A key HAUSPfunction is to bind and deubiquitinate the p53 transcription factor and an associated regulatorprotein Mdm2

Copyright © 2021 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by